C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
GTBIF US MSO

Green Thumb Industries

OTCMKTS · GTBIF

Vertically integrated MSO operating in 15 markets. Known for premium brands (RYTHM, Dogwalkers, Beboe) and strong margins.

Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
60/100 composite
Fundamentals77
Regulatory73
Market40
Editorial30
Composite · trailing 12 months

Green Thumb Industries earns a Neutral rating with a composite score of 59.83, reflecting a company delivering operational excellence in fundamentals yet facing muted market visibility and minimal editorial momentum. The operator demonstrates textbook execution on the pillar that matters most: its fundamentals subscore registers 77.38, anchored by an 87.4 operating-margin subscore and an 80.2 gross-margin subscore that confirm disciplined cost management and pricing power. Positive EBITDA generation eliminates balance-sheet risk, while the market-cap tier subscore of 87.7 places the firm comfortably among the sector's larger players. Revenue expansion has moderated—reflected in a 57.4 revenue-growth subscore—but margin integrity more than compensates, positioning the company to convert top-line stability into sustained profitability.

Regulatory conditions remain supportive, with a 73.0 pillar score driven by an 80.0 jurisdiction subscore tied to Canadian domicile and zero enforcement hits over the trailing six months. Filing cadence lands at 62.5, indicating steady but unremarkable disclosure rhythm. The weakness lies elsewhere: market and editorial pillars score 40.0 and 30.0, respectively, signaling absent price discovery and negligible newsroom attention. Without tradable equity quotes or media catalysts, investor sentiment remains dormant despite strong operational performance.

The critical variable is whether Green Thumb can catalyze market liquidity or trigger editorial coverage through a liquidity event, strategic transaction, or material operational disclosure that bridges the gap between private execution and public recognition.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
325 WEST HURON STREET, SUITE 700, CHICAGO, IL, 60654
Phone
312-471-6720
Auditor
as stated in their attestation report
SEC CIK
1795139
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$1.56B
Enterprise value
$1.77B
P/E ratio
13.9
PEG ratio
1.79
Price to book
0.82
Price to sales
1.30
EV / EBITDA
3.48
Revenue (TTM)
$1.20B
Gross profit (TTM)
$575.3M
EBITDA
$284.4M
Operating margin
13.6%
Profit margin
10.1%
Rev growth YoY
7.4%
Return on equity
6.6%
Return on assets
3.1%
EPS (TTM)
$0.51
EPS est. current year
$0.12
Wall St. target price
$15.67
Shares outstanding
195.1M
Insider ownership
1.9%
Institutional ownership
8.2%
Beta
0.93
Full-time employees
4,900
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Green Thumb Industries (GTBIF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Green Thumb Industries (GTBIF), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, insider selling. (2 bullish signals, 3 bearish signals.)

Vertically integrated MSO operating in 15 markets. Known for premium brands (RYTHM, Dogwalkers, Beboe) and strong margins.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for GTBIF are maintained by Cannabis Investor News and refreshed throughout the trading day.